Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
Clinical trial NCT00454168 · UNKNOWN
Trial details
- NCT number
- NCT00454168
- Sponsor
- The Vaccine Company
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2009-04-01
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.